Biotech

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

German biotech, Ovo Labs, claims breakthrough treatment could nearly halve chromosome errors in eggs, potentially transforming success rates for women over 35.

Unexpected Protein Structure May Lead to New Cancer Treatments

University of Iowa researchers have uncovered an unexpected double-ring structure in the DNA repair protein RAD52, revealing new insights that could guide the development of next-generation cancer drugs.

Cyclana Bio Secures £5M to Transform Drug Discovery for Endometriosis

Cambridge-based biotech pioneers tissue-level approach to women's health, aiming to close the gender gap in medical innovation.

Bio-Rad and Gencurix Expand European Access to Precision Cancer Testing

Exclusive distribution deal will bring Droplex digital PCR diagnostic kits to more laboratories across Europe, supporting biomarker-driven treatment decisions in major cancers.

Tagomics Breakthrough Study Showcases New Epigenomic Profiling Technology in Cell Reports Methods

Cambridge biotech’s Activace™ platform offers a scalable, DNA-preserving method to unlock cancer biomarkers from liquid biopsies

Genmab to Acquire Merus in $8B Deal, Adding Breakthrough Oncology Asset to Late-Stage Pipeline

$8B acquisition brings late-stage bispecific antibody petosemtamab into Genmab’s pipeline, accelerating shift to a wholly owned model with potential blockbuster launches by 2027.